These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20960270)

  • 1. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
    Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Alvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
    Endocrine; 2010 Apr; 37(2):322-8. PubMed ID: 20960270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
    Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Álvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
    Endocrine; 2010 Feb; 37(1):180-6. PubMed ID: 20963568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis.
    Giner M; Rios MJ; Montoya MJ; Vázquez MA; Miranda C; Pérez-Cano R
    Eur J Pharmacol; 2011 Jan; 650(2-3):682-7. PubMed ID: 21050847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in otosclerotic and normal human stapedial osteoblast properties are normalized by alendronate in vitro.
    Gronowicz G; Richardson YL; Flynn J; Kveton J; Eisen M; Leonard G; Aronow M; Rodner C; Parham K
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):657-66. PubMed ID: 25085325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts].
    Dong W; Qi M; Deng J; Chen H; Feng X; Liao N
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1695-8. PubMed ID: 23268391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
    Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
    Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
    J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.
    Tat SK; Pelletier JP; Vergés J; Lajeunesse D; Montell E; Fahmi H; Lavigne M; Martel-Pelletier J
    Arthritis Res Ther; 2007; 9(6):R117. PubMed ID: 17996099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
    Brennan TC; Rybchyn MS; Green W; Atwa S; Conigrave AD; Mason RS
    Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
    Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
    Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.
    Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X
    J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
    Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
    Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain.
    Jacobs C; Grimm S; Ziebart T; Walter C; Wehrbein H
    Arch Oral Biol; 2013 Jul; 58(7):896-904. PubMed ID: 23422327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of compressive loading and incubation with clodronate on the RANKL/OPG system of human osteoblasts.
    Grimm S; Walter C; Pabst A; Goldschmitt J; Wehrbein H; Jacobs C
    J Orofac Orthop; 2015 Nov; 76(6):531-42. PubMed ID: 26446504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts.
    Kaneko K; Kusunoki N; Hasunuma T; Kawai S
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1909-17. PubMed ID: 22791764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
    Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model.
    Zhu S; Häussling V; Aspera-Werz RH; Chen T; Braun B; Weng W; Histing T; Nussler AK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.